CS MEDICA announces voluntarily extension of lock-up agreement for CEO and CFO
CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that CEO Lone Henriksen as well as CFO Gitte Lund Henriksen have extended their lock-up agreements for their shares in the Company until August 2023. In total, the lock-up agreements correspond to approximately 74 percent of the votes and capital in CS MEDICA.
CEO Lone Henriksen and CFO Gitte Lund Henriksen at CS MEDICA have extended their existing lock-ups for 12 months until end of August 2023. The original lock-up agreement was entered in connection with the listing on Spotlight Stock Market in August 2021. The lock-up prevents the selling of shares.
“We strongly believe in CS MEDICA’s bright future and by extending our lock-up agreement it reconfirms our commitments to the future development of the Company and we have no intention of selling our shares now,” says CEO Lone Henriksen.
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.
BioStock: Iconovos vd om anslaget från Bill & Melinda Gates Foundation
Iconovo har erhållit ett anslag på 9 Mkr från Bill & Melinda Gates Foundation för att snabbt kunna bygga upp en storskalig tillverkning av inhalationsbehandlingar i händelse av en ny pandemi. Projektet baseras på inhalatorn ICOone Nasal och planeras att genomf&o...
Bioservo tecknar avtal om försäljning av Carbonhand[®] med Rehasys i Schweiz
Rehasys är en av Schweiz ledande leverantörer av tekniska och medicinska hjälpmedel samt rehabiliteringsutrustning för personer med begränsad rörlighet. Bolaget grundades 1926 och har idag en stor kundbas och vänder sig till hälsoinstitutioner såsom reha...
Bioservo signs an agreement for the sale of Carbonhand[®] with Rehasys in Switzerland
Rehasys is one of Switzerland's leading suppliers of technical and medical aids and rehabilitation equipment for people with limited mobility. The company was founded in 1926 and today has a large customer base and caters to health institutions such as rehabilitation clinics, hospitals, nursing...